BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 16738017)

  • 1. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
    Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
    J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated prorenin as a therapeutic target for diabetic nephropathy.
    Ichihara A; Sakoda M; Mito-Kurauchi A; Itoh H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S63-6. PubMed ID: 18922597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.
    Ichihara A; Hayashi M; Kaneshiro Y; Suzuki F; Nakagawa T; Tada Y; Koura Y; Nishiyama A; Okada H; Uddin MN; Nabi AH; Ishida Y; Inagami T; Saruta T
    J Clin Invest; 2004 Oct; 114(8):1128-35. PubMed ID: 15489960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade.
    Takahashi H; Ichihara A; Kaneshiro Y; Inomata K; Sakoda M; Takemitsu T; Nishiyama A; Itoh H
    J Am Soc Nephrol; 2007 Jul; 18(7):2054-61. PubMed ID: 17538189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
    Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
    Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
    Pan Y; Huang Y; Wang Z; Fang Q; Sun Y; Tong C; Peng K; Wang Y; Miao L; Cai L; Zhao Y; Liang G
    J Cell Mol Med; 2014 Feb; 18(2):231-41. PubMed ID: 24330074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin, prorenin and the kidney: a new chapter in an old saga.
    Ichihara A; Sakoda M; Kurauchi-Mito A; Kaneshiro Y; Itoh H
    J Nephrol; 2009; 22(3):306-11. PubMed ID: 19557706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-independent upregulation of cyclooxygenase-2 by activation of the (Pro)renin receptor in rat renal inner medullary cells.
    Gonzalez AA; Luffman C; Bourgeois CR; Vio CP; Prieto MC
    Hypertension; 2013 Feb; 61(2):443-9. PubMed ID: 23184385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
    te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?
    Fekete A; Rosta K; Wagner L; Prokai A; Degrell P; Ruzicska E; Vegh E; Toth M; Ronai K; Rusai K; Somogyi A; Tulassay T; Szabo AJ; Ver A
    J Physiol; 2008 Nov; 586(22):5337-48. PubMed ID: 18818245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy.
    Clotet-Freixas S; Soler MJ; Palau V; Anguiano L; Gimeno J; Konvalinka A; Pascual J; Riera M
    Lab Invest; 2018 Sep; 98(9):1237-1249. PubMed ID: 29884907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
    Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R
    Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.
    Kaneshiro Y; Ichihara A; Sakoda M; Takemitsu T; Nabi AH; Uddin MN; Nakagawa T; Nishiyama A; Suzuki F; Inagami T; Itoh H
    J Am Soc Nephrol; 2007 Jun; 18(6):1789-95. PubMed ID: 17494887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats.
    Feldman DL; Jin L; Xuan H; Contrepas A; Zhou Y; Webb RL; Mueller DN; Feldt S; Cumin F; Maniara W; Persohn E; Schuetz H; Jan Danser AH; Nguyen G
    Hypertension; 2008 Jul; 52(1):130-6. PubMed ID: 18490518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor.
    Thomas CM; Yong QC; Seqqat R; Chandel N; Feldman DL; Baker KM; Kumar R
    Clin Sci (Lond); 2013 Apr; 124(8):529-41. PubMed ID: 23116220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation.
    Matavelli LC; Huang J; Siragy HM
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):277-82. PubMed ID: 19769609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy.
    Jacobsen P; Rossing K; Parving HH
    Curr Opin Nephrol Hypertens; 2004 May; 13(3):319-24. PubMed ID: 15073491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
    Zhang Y; Deb DK; Kong J; Ning G; Wang Y; Li G; Chen Y; Zhang Z; Strugnell S; Sabbagh Y; Arbeeny C; Li YC
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F791-801. PubMed ID: 19535571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.